Resolving patient heterogeneity in critical illness requires multi-scale approaches.
Resolving patient heterogeneity in critical illness requires multi-scale approaches.
复制标题
DOI:
10.1016/j.ebiom.2022.103918
复制
发表时间:
2022-03
期刊:
影响因子:
11.1
通讯作者:
Scicluna BP
中科院分区:
文献类型:
--
作者:
Scicluna BP
Environmental exposures, including microbes, toxic substances, and vaccines, can significantly impact the functional state of immune cells. It is now accepted that cell identity and functional states are governed by tightly regulated spatiotemporal gene expression programs. Establishing cell type identity depends largely on the coordinated distribution of numerous transcription factors that bind to accessible chromatin regions harbouring cis-regulatory elements, thereby activate or repress gene expression (Figure 1 A). 1 Therefore, identifying the accessible cis-elements in the genome of specific celltypes is an essential step towards a deeper understanding of health and disease. Considering accessible cisregulatory elements are typically hypersensitive to nucleases or transposases (whether active or poised), the Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) 2 has been widely used to map chromatin accessibility patterns (Figure 1 B). To overcome the limitations of complex tissue samples in resolving cell specific events, methods were recently developed for measuring chromatin accessibility at the level of single cells (scATAC-seq). Transcriptional profiling of blood leukocytes obtained from critically ill patients due to severe trauma and burn injuries revealed substantial alterations in gene expression that were associated with extent of organ dysfunction and outcomes. 3 Applying single cell RNA-sequencing to peripheral blood mononuclear cells (PBMCs) obtained from trauma patients, revealed gene expression patterns in myeloid cells (mainly monocytes) contributed markedly to departure from steady state. 4 Notably, gene expression changes in key transcription factors could be attributed to the myeloid progenitor pool. Whether those trauma-induced gene expression changes reflected chromatin accessibility patterns was an open question. In this issue of eBioMedicine, Chen and colleagues addressed this question by testing chromatin accessibility using scATAC-seq in PBMCs obtained from trauma patients. 5 As expected, gene expression alterations were largely concomitant with open chromatin conformations, which the authors stratified as either “focal” loci, associated with well-characterized inflammatory and immune suppressive gene sets, or “global” loci characterized by gene expression changes attuned to pathways unspecific to the immune response, including de-repression of Polycomb targets, suppression of genes involved in DNA repair and RNA processing. This “global epigenetic signature” was subsequently explored in large datasets of whole-blood leukocyte transcriptomes and the associated clinical outcomes from trauma, severe burns, 3 and sepsis 6, 7 cohorts. Using a gene filtering bioinformatics strategy, the authors found that, firstly, combining the “global” epigenetic alterations (designated EG subtypes) with an inflammatory response transcriptomic signature (termed SG subtypes), which was previously derived by the same group, provided better resolution of patient heterogeneity in critical illness due to trauma than using either EG or SG subtypes in isolation. Moreover, and intriguingly, higher expression of genes associated with the “global” epigenetic group was associated with worse outcomes in critical illness due to burns or sepsis. The potential prognostic value of the epigenetic group subtypes was independent of transcriptional changes of genes involved in typical immune response pathways, including pro-, anti-inflammatory signalling, antigen presentation, and interferon signalling pathways, which were associated with transcriptomic SG subtypes in the group’s previous study, and also defined …
登录
查看更多内容
影响因子:
81.5
作者:
Matthay, Michael A.;Zemans, Rachel L.;Calfee, Carolyn S.
通讯作者:
Calfee, Carolyn S.
DOI:
10.1084/jem.20111354
发表时间:
2011-12-19
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Xiao W;Mindrinos MN;Seok J;Cuschieri J;Cuenca AG;Gao H;Hayden DL;Hennessy L;Moore EE;Minei JP;Bankey PE;Johnson JL;Sperry J;Nathens AB;Billiar TR;West MA;Brownstein BH;Mason PH;Baker HV;Finnerty CC;Jeschke MG;López MC;Klein MB;Gamelli RL;Gibran NS;Arnoldo B;Xu W;Zhang Y;Calvano SE;McDonald-Smith GP;Schoenfeld DA;Storey JD;Cobb JP;Warren HS;Moldawer LL;Herndon DN;Lowry SF;Maier RV;Davis RW;Tompkins RG;Inflammation and Host Response to Injury Large-Scale Collaborative Research Program
通讯作者:
Inflammation and Host Response to Injury Large-Scale Collaborative Research Program
影响因子:
64.8
作者:
Shen, Yin;Yue, Feng;McCleary, David F.;Ye, Zhen;Edsall, Lee;Kuan, Samantha;Wagner, Ulrich;Dixon, Jesse;Lee, Leonard;Lobanenkov, Victor V.;Ren, Bing
通讯作者:
Ren, Bing
影响因子:
76.2
作者:
Scicluna, Brendon P.;van Vught, Lonneke A.;van der Poll, Tom
通讯作者:
van der Poll, Tom
影响因子:
8.8
作者:
DeMerle KM;Angus DC;Baillie JK;Brant E;Calfee CS;Carcillo J;Chang CH;Dickson R;Evans I;Gordon AC;Kennedy J;Knight JC;Lindsell CJ;Liu V;Marshall JC;Randolph AG;Scicluna BP;Shankar-Hari M;Shapiro NI;Sweeney TE;Talisa VB;Tang B;Thompson BT;Tsalik EL;van der Poll T;van Vught LA;Wong HR;Yende S;Zhao H;Seymour CW
通讯作者:
Seymour CW